-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Repligen, Raises Price Target to $190

Benzinga·12/15/2025 18:29:21
语音播报
Wells Fargo analyst Brandon Couillard maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $175 to $190.